InsiderTrades

Form 4 for BSEM BioStem Technologies, Inc.

Accepted 2026-09-17 16:30:08 ET · period of report 2026-09-15 · accession 0001193125-26-394398 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-09-17 16:30 2026-09-15+ BSEM Matuszewski Jason CEO, Dir, 10% M - OptEx $0.00 +25.1K 1.30M +2% $0
DM 2026-09-17 16:30 2026-09-15+ BSEM Matuszewski Jason CEO, Dir, 10% M - OptEx $0.00 -25.1K 99.9K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-09-15 M A 8,469 $0.00 1,286,902 D — —
2 Common Common Stock 2026-09-17 M A 16,650 $0.00 1,303,552 D — —
3 Derivative Restricted Stock Units 2026-09-15 M D 8,469 $0.00 33,874 D — · — to — 8,469 Common Stock (F5) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F6) These restricted stock units vest quarterly over three years from the grant date (September 15, 2024). (F6) These restricted stock units vest quarterly over three years from the grant date (September 15, 2024).
4 Derivative Restricted Stock Units 2026-09-17 M D 16,650 $0.00 99,900 D — · — to — 16,650 Common Stock (F5) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F7) These restricted stock units vest according to the following schedule: 33% vested on March 17, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period. (F7) These restricted stock units vest according to the following schedule: 33% vested on March 17, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.